WEST$3.92
$4.11
Chart
Performance
Key Stats
AI WEST Summary
Powered by LiveAIAI Scoreboard
Powered by LiveAIOverall Analysis
HoldWestrock Coffee Company exhibits mixed signals. Fundamentally, the company is struggling with profitability and cash flow, while its debt levels are concerning. Technically, there are some short-term bullish indicators, but the overall trend appears weak. Thematic exposure is limited, suggesting investors should exercise caution.
Thematic
Westrock Coffee's operations are within the beverage sector, which has stable demand but limited exposure to high-growth disruptive themes like AI or sustainable energy. Its focus on coffee and tea sourcing and solutions does not currently align with major emerging market themes.
Fundamental
Westrock Coffee is experiencing significant financial challenges, with consistent net losses, negative free cash flow, and a growing debt burden. Revenue has been somewhat stable but is not translating into profitability.
Technical
While the stock has shown some recent positive momentum, it is trading below key long-term moving averages, suggesting underlying weakness. Overbought conditions on shorter timeframes might precede a minor pullback.
| Factor | Score |
|---|---|
| Consumer Staples Demand | 60 |
| Sustainability & Ethical Sourcing | 50 |
| Innovation in Beverage Technology | 30 |
| Global Supply Chain Resilience | 50 |
| Factor | Score |
|---|---|
| Valuation | 40 |
| Profitability | 15 |
| Growth | 30 |
| Balance Sheet Health | 45 |
| Cash Flow | 10 |
| Factor | Score |
|---|---|
| Trend Analysis | 40 |
| Momentum | 65 |
| Volume Confirmation | 50 |
| Support & Resistance | 70 |
AI Investing Checklist
Powered by LiveAIBullish Points (7)
Positive Short-Term Momentum
The stock has shown positive performance over the last 1 month (+17.98%) and 5 days (+3.69%), indicating recent investor interest.
Low Beta
With a beta of 0.508, the stock is less volatile than the overall market, suggesting lower systematic risk.
Bearish Points (13)
Consistent EPS Misses
The company has consistently missed earnings estimates, with significant negative surprises in recent quarters (e.g., Q2 2025: -38.1%, Q1 2025: -122.85%).
Negative Earnings Per Share (EPS) TTM
The EPS TTM is -0.91, indicating the company is currently unprofitable on a per-share basis over the last twelve months.
Calendar
August 2025
8
Next Earnings Date
H: $-0.17
A: $-0.17
L: $-0.17
H: 252.80M
A: 238.34M
L: 230.90M
Profile
Westrock Coffee Company, LLC operates as an integrated coffee, tea, flavors, extracts, and ingredients solutions provider in the United States and internationally. It operates through two segments, Beverage Solutions, and Sustainable Sourcing & Traceability (SS&T). The Beverage Solutions segment provides various packaging, including branded and private label coffee in bags, fractional packs, single serve cups, multi-serve bottles, and ready-to-drink bottles and cans, as well as extract solutions for applications in cold brew and ready-to-drink offerings. The SS&T segment engages in delivery and settlement of forward sales contracts for green coffee. The company offers coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to the retail, food service and restaurant, convenience store and travel center, non-commercial account, CPG, and hospitality industries. Westrock Coffee Company, LLC was founded in 2009 and is headquartered in Little Rock, Arkansas.
Seasonals
Price Target
10.60 USD
The 39 analysts offering 1 year price forecasts for WEST have a max estimate of 13.00 and a min estimate of 10.00.
Debt Level and Coverage
Financial Position Analysis
Ownership
Capital Structure
Valuation - Summary
Valuation - Ratios
Revenue to Profit Conversion
Balance Sheet
Income Statement
Cash Flow
Related Companies
Powered by LiveAIWeight: 95
Direct competitor in pharmaceutical glass primary packaging and drug delivery systems, offering similar product lines and serving the same pharmaceutical client base as West Pharmaceutical Services.
Weight: 90
A major direct competitor in pharmaceutical primary packaging, drug delivery devices, and medical plastic systems, with significant overlap in product offerings and customer segments.
Weight: 85
A key peer and competitor in the design and manufacturing of dispensing and drug delivery systems for the pharmaceutical, beauty, and food markets, sharing technology and market focus with WST in drug delivery.
Weight: 80
A global medical technology company that manufactures a wide range of medical devices, including pre-filled syringe systems and other drug delivery components, which are direct or complementary to WST's offerings.